Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionJennison Associates Llc
Latest Disclosed Ownership115,199 shares
Latest Disclosed Value $ 89,007,355
Jennison Associates Llc ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 6, 2026 - Jennison Associates Llc filed a 13F-HR form disclosing ownership of 115,199 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $89,007,355 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 8, 2024 disclosing 0 shares of Regeneron Pharmaceuticals, Inc..

Jennison Associates Llc has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 115,199 115,199 89,007 0.0328
2024-11-08 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -99,802 -100.00 0 -100.00
2024-08-05 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 99,802 66,281 197.73 104,895 225.12 0.0672
2024-05-02 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 33,521 33,521 32,264 0.0216
2023-08-03 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -28,090 -100.00 0 -100.00
2023-04-26 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 28,090 28,090 23,081 0.0212
2022-02-08 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -1,805 -100.00 0 -100.00
2021-11-09 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,805 1,805 1,092 0.0007
2021-08-12 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -10,061 -100.00 0 -100.00
2021-05-11 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 10,061 10,061 4,760 0.0035
2021-02-05 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -66,884 -100.00 0 -100.00
2020-11-04 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 66,884 -1,673 -2.44 37,440 -12.43 0.0301
2020-08-06 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 68,557 22,157 47.75 42,756 88.71 0.0386
2020-05-06 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 46,400 43,068 1,292.56 22,657 2,072.29 0.0275
2019-08-06 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,332 -83 -2.43 1,043 -25.61 0.0010
2019-05-10 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,415 3,415 1,402 0.0014
2018-08-02 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -88,815 -100.00 0 -100.00
2018-04-20 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 88,815 13,022 17.18 30,584 7.33 0.0304
2018-01-25 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 75,793 -1,123,954 -93.68 28,495 -94.69 0.0281
2017-11-03 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,199,747 -93,116 -7.20 536,431 -15.52 0.5494
2017-08-04 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,292,863 532,547 70.04 634,977 115.52 0.6735
2017-08-02 2017-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 760,316 -1,156,625 -60.34 294,630 -58.13 0.3161
2017-04-28 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 759,960 -1,156,981 294,492
2017-08-02 2016-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 1,916,941 -205,207 -9.67 703,690 -17.52 0.7856
2017-02-06 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,916,169 -205,979 703,406
2016-11-01 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,122,148 91,223 4.49 853,146 20.29 0.9196
2016-08-03 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,030,925 -20,934 -1.02 709,260 -4.10 0.7782
2016-05-03 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,051,859 35,832 1.78 739,572 -32.42 0.7762
2016-02-10 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,016,027 93,894 4.88 1,094,441 22.41 1.0743
2015-11-06 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,922,133 189,407 10.93 894,061 1.15 0.9515
2015-08-03 2015-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,732,726 1,732,726 883,916 0.8103
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-08-04 2017-06-30 13F REGENERON PHARMACEUTICALS PUT OPTIONS Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-02 2017-03-31 13F/A REGENERON PHARMACEUTICALS PUT OPTIONS Put 17,700 0.00 6,859 5.57 n/a n/a n/a
2017-04-28 2017-03-31 13F REGENERON PHARMACEUTICALS PUT OPTIONS Put 17,700 6,859 n/a n/a n/a
2017-08-02 2016-12-31 13F/A REGENERON PHARMACEUTICALS PUT OPTIONS Put 17,700 6,497 n/a n/a n/a
2017-02-06 2016-12-31 13F REGENERON PHARMACEUTICALS PUT OPTIONS Put 17,700 6,497 n/a n/a n/a
2016-08-03 2016-06-30 13F REGENERON PHARMACEUTICALS PUT OPTIONS Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-03 2016-03-31 13F REGENERON PHARMACEUTICALS PUT OPTIONS Put 18,600 6,704 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.